F, D. P., P, P., N, V., L, M., S, M., & G, M. (2013). Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Dove Medical Press.
Chicago Style (17th ed.) CitationF, Di Pierro, Putignano P, Villanova N, Montesi L, Moscatiello S, and Marchesini G. Preliminary Study About the Possible Glycemic Clinical Advantage in Using a Fixed Combination of Berberis Aristata and Silybum Marianum Standardized Extracts Versus Only Berberis Aristata in Patients with Type 2 Diabetes. Dove Medical Press, 2013.
MLA (8th ed.) CitationF, Di Pierro, et al. Preliminary Study About the Possible Glycemic Clinical Advantage in Using a Fixed Combination of Berberis Aristata and Silybum Marianum Standardized Extracts Versus Only Berberis Aristata in Patients with Type 2 Diabetes. Dove Medical Press, 2013.